Biochemistry
 |
|
12 october 2017 18:36:04 |
| The Therapeutic Antibody LM609 Selectively Inhibits Ligand Binding to Human ?V?3 Integrin via Steric Hindrance (Structure) |
|
Tweet The LM609 antibody specifically recognizes ?V?3 integrin and has been employed in numerous clinical and academic research applications. In this article, Borst et al. shed light on the mode of action of a widely used integrin-targeting antibody. |
| 135 viewsCategory: Biochemistry |
 The structure-energy landscape of NMDA receptor gating (Nature Chemical Biology)Introduction to the Thematic Minireview Series: Redox metabolism and signaling [Metabolism] (Journal of Biological Chemistry) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
